VASO CORPORATION

VASO ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $72.8M $72.6M $57.1M $35.0M $32.9M $29.2M $31.1M $4.2M
Cost of Revenue $32.1M $31.1M $21.7M $9.8M $10.4M $8.6M $5.5M $2.0M
Gross Profit $40.7M $41.5M $35.4M $25.2M $22.5M $20.6M $21.9M $2.2M
Gross Margin 56.0% 57.2% 62.0% 72.1% 68.4% 70.4% 70.4% 52.6%
Operating Expenses
Research & Development $945.0K $530.0K $515.0K $803.0K $689.0K $576.0K $462.0K $419.0K
SG&A Expense $43.6M $39.4M $30.9M $23.3M $23.1M $23.5M $14.4M $3.8M
Operating Income $-3.8M $1.6M $3.9M $1.1M $-1.3M $-3.5M $3.7M $-2.0M
Operating Margin -5.3% 2.2% 6.9% 3.0% -3.9% -12.0% 11.9% -47.1%
Interest Expense
Pretax Income $-4.4M $1.1M $3.8M $1.3M $-1.2M $-3.3M $3.9M $-1.9M
Income Tax Expense $134.0K $281.0K $-44.0K $127.0K $-58.0K $52.0K $7.0K $-36.0K
Net Income $-4.5M $820.0K $3.8M $1.1M $-1.1M $-3.4M $3.6M $-1.8M
Net Margin -6.2% 1.1% 6.7% 3.2% -3.5% -11.6% 11.7% -43.2%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 164.97B 161.84B 159.37B 158.00B 162.09B 161.06B 151.94B 116.34T
Shares Outstanding (Diluted) 164.97B 162.11B 159.86B 158.68B 162.09B 161.06B 161.08B 116.34T
Dividends Per Share
← Newer Page 2 of 2 Older →